To support 2-HG synthesis, cancer cells with IDH1 R132H mutation enhance NADPH production via the PPP
De Strooper, B., Vassar, R
BPC 157 has been extensively studied in various clinical trials for its regenerative effects on various bodily tissues, including muscles, tendons, ligaments, and the gastrointestinal tract and may modulate vascular endothelial growth factor (VEGF) expression, promoting healing by enhancing the formation and growth factor of new blood vessels
Immunosource), 100 mM phosphate buffer (pH 7.2), and 0.1% Triton
Researchers studying musculoskeletal injuries have noted that BPC-157's angiogenic properties complement TB-500's cell migration-promoting effects, creating a more complete tissue repair environment in experimental settings